pagiantmetknicksfan@yahoo.com
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Say, which drugs are pending transfer and or launch right now?
No obviously it's true. So which products are in trials right now and pending a result announcement?
Well obviously that is false. Can you tell me where Zogenix provided their trial data from their reformulation to make it ADT?
So which products are which trials are pending right now? Really a simple question.
LOL...Say which trial results are due to be announced here? Which products and which trials?
Based on what we know such as meetings with heads of major Pharmas (One's they didn't even know would be interested), I suspect the buyout comes sooner then later. We should see another launch here soon of the generics.
Looking at the acquisition landscape, things are lining up. Anyone interested should look into what these major Pharmas are doing...
That is where it is really going to get interesting. We all know the product works. Note how no one has anything legitimately bad to say about the technology. We all know it works and we all know it will be approved. The question becomes how fast can they assembly line them out the door. Seems it will be very fast.
Yeah. Very good talent. The other senior exec hire before these was top notch too.
We have covered this before. People that are experienced in the Pharma market understand that BE trials aren't required to be listed there. Where are Zogenix trials listed for their reformulation of Zohydro. They aren't there either..which is also obvious.
Just like some have come to understand that folks are being compensated to spread false and misleading information in order to harm the stock as it is being accumulated. Some believe it is in anticipation of a buyout or the next run up...
The key thing to look for is misinformation by sources that claim to not have an interest and don't care about key items with the company. Places such as Hotstocked or other outlets that continue to spread misinformation but have a hard time actually presenting anything about the company.
With numerous drugs in trials, and results have been extremely positive I am sure it is worth it. Attracting top talent is a huge sign of things to come.
Yeah...thought that was interesting. Very serious hires recently. Another question is how many drugs get filed this year too?
The further this goes, the more expensive it becomes to buyout...Each drug trial adds significant value as the pipeline grows. So when people say "who cares"...the answer obviously is...people paying attention
Dilution is a non starter right now. O/S has only changed about 15% in the past year
And that is the truth...
So you are saying the trial results will be great and noted in a PR. How can the results be great and be meaningless. I don't think accusing the company and Camargo of falsifying their statements to be appropriate. Do you have any evidence that anything was falsified?
I am betting that Eli 202 is Percodan. You think I am right?
I am sure investors like myself are excited about the next release of trial results. You think they are trialing the 4th ADT opioid soon?
Say I believe a partner announcement is coming too. Very exciting.
So which trial results by Elite and Camargo to be released here shortly? Oxycodone HAL study...pivotal BE on Eli 200? Which drug do you think Eli 202 is?
How many trials are in process and how many results are about to be announced?
That is pretty much it...
If you say so...You are obviously incorrect....
Like I said before you can go from California to Arizona...heck you can stop over in Oregon too...but home is sometimes where your feet are.
We all know Elite is going to get bought out....
I am not sure you can call that an article but whatever it was, the comments were hilarious and much more informative then the article.
It's like taking a trip from California to Arizona. Wherever you plant your feet is home I guess. Good luck on your article.
Yes facts. Please present them.
I think you mean hotstocked.com. Basically a false and misleading article on Elite every day....pretty obvious that there is a concerted effort to spread misinformation and distract investors and potential investors. ...unless you believe there is an incredible amount of interest in shorting Elite in Bulgaria.
How much does it cost to get them to publish an article? Can he much since they published about 20 last year....
Well then your article should get published if that's true. Can't wait to read it....
Not sure how "can you tell me the previous CEOs name" is very exciting to read about though.
I doubt it. I believe they have some minimum standards.
Why didn't you try google? I bet you can find the answer there...not that the answer means anything....
So you are saying that there are 14 drugs pending launch now? Thats awesome. I don't know where you get that they are not working to launch them though. Based on how things go, this seems to be normal.
Which generics has he not launched...or you mean Epic.
How many drugs are pending launch Richme?
You mean trading? That goes on in every stock every day?
Because it was up to the FDA and that some small studies may also be required and they wanted to make sure the FDA was 100% comfortable before they filed and then have the FDA ask for something else three months later complicating the situation.
Again, I am betting that Elite's stellar management and Camargo the leading 505B2 expert, have got this under control.
Trying to say that Elite did not meet some deadline would be a gross mis-characterization of the facts and numerous quotes and statements from conference calls. If you have some new data to present, let's hear it but saying the same thing over and over in the face of direct quotes from the company is not a winning argument.
Well since as presented here numerous times, they said that they would be ready and they are...
...and they noted there might be something else small that is needed and this is from their discussions with the FDA....
....and here we are...
So again the information and direct quotes have been presented numerous times indicating that the CEO said they would be ready...Do you have new information that I am unaware of or can we go with the numerous quotes from the company?
I wonder if Camargo and Nasrat come here prior to checking with the FDA?
Different products. And Zohydro didn't just change things, they fully added a new component to an existing drug. The drugs you mention are all on the same bead. Just saying agonist/antagonist doesn't mean anything. It is a red herring argument.
Adding items that gel with water is not just adding excipients....Purdue did Ph3 for their hard shell products too right? And Zohydro didn't...products just adding excipients too right so your example is obviously a bad one.
Now we can believe Camargo and Elite and their discussions with the FDA or we can believe your bad example here? hmmmmmm.....
Actually all that has occurred is attempts by MMs to hold the price down. It moves quite fast on very little volume...indicating how much manipulation there is to bring it to the current price.
Thanks for the lack of detailed explanation to prove what I noted was wrong....lol
It has everything to do with it. Zohydro updated their formulation right?
Elite can update a generic formulation via 505B2......
Why does one process to update a formulation for one drug that is approved have to be significantly different in process from another. Elite is filing a 505B2 NDA too.
Actually if you read the SA article, it explains this pretty well.
Elite has approval to market Hydromorhone at minimum...Epic had approval for Oxycontin....
Zohydro was approved as are the generics out there already...
I do too. Very exciting. The numbers should be solid. I believe this is the one where we should see the Phendametrazine bump too. But obviously I am looking forward to hearing ART news
Hotstocked...three articles in three days? Is that right? I know no one takes them seriously but that is impressive stuff
Exactly Hike. Adding inactive beads that are proven to pass through the body would certainly qualify. What would you possibly test anyway in an efficacy trial that you didn't already know? Opioids have relieved pain and been on the market forever. Elite already makes generic opioids.
FDA had never seen anything like ELite's product before....until possibly this Zohydro situation
That is why the leading 505B2 company in Camargo and Elite in discussions with the FDA have given the recent timeline and that current plans to launch in 2015 should not be impacted. The company has been several steps ahead of investors for awhile now. I expect the next information to be that they are done with whatever else the FDA would have liked to see.
Based on the trading and misleading Hotstocked articles, it is clear that the manipulators behind these items certainly wouldn't want folks thinking about this.